Stay updated with breaking news from Dalton Bioanalytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent study led by UC Davis Health researchers provides new insights into the molecular changes linked to the rare genetic condition 22q11.2 deletion syndrome, or 22q.
A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.
A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.
Cary-based Atom Bioworks (Atombio) has been selected as one of 14 promising global life-sciences startups to participate in the BioTools Innovator Accelerator program.